(Q69677732)
Statements
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal Group (English)
J Wils
H Bleiberg
M Buyse
D T Wagener
T Splinter
C Veenhof
M Herben